Development of a Commercial Process for Odalasvir-Reference-Cited by-同舟云学术

Development of a Commercial Process for Odalasvir

Published:2021-12-15 Issue: Volume: Page:
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Tran Duc N.¹^ORCID,Zhdanko Alexander¹,Barroso Santiago¹,Nieste Patrick¹,Rahmani Ramdane¹,Holan Jan¹,Hoefnagels Roel¹,Reniers Peter¹,Vermoortele Frederik¹,Duguid Stewart²,Cazanave Lionel²,Figlus Marek²,Muir Colin²,Elliott Alain²,Zhao Peichao²,Paden Warren²,Diaz Cristina Hernandez²,Bell Stephen J.²,Hashimoto Akihiro³,Phadke Avinash³,Wiles Jason A.³^ORCID,Vogels Ilse¹,Farina Vittorio¹

Affiliation:

1. Chemical Process R&D, Janssen Pharmaceutica, 2340 Beerse, Belgium

2. Department of Process Development, Almac Sciences, 20 Seagoe Industrial Estate, Craigavon BT63 5QD, United Kingdom

3. Department of Chemistry, Achillion Pharmaceuticals, Inc., 300 George Street, New Haven, Connecticut 06511, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.1c00237

Reference19 articles.

1. Global epidemiology of hepatitis C virus infection